🇺🇸 FDA
Pipeline program

Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval

VABIOTECH-01

Unknown mab completed

Quick answer

Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval for Diphtheria is a Unknown program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Diphtheria
Phase
Unknown
Modality
mab
Status
completed

Clinical trials